Expression of c-Src and phospho-Src in epithelial ovarian carcinoma.
about
A Synthetic Lethality Screen Using a Focused siRNA Library to Identify Sensitizers to Dasatinib Therapy for the Treatment of Epithelial Ovarian CancerDasatinib enhances antitumor activity of paclitaxel in ovarian cancer through Src signaling.Phosphorylated c-Src is a novel predictor for recurrence in cervical squamous cell cancer patientsGenome-wide methylation profiling of ovarian cancer patient-derived xenografts treated with the demethylating agent decitabine identifies novel epigenetically regulated genes and pathways.Overexpression of ASAP1 is associated with poor prognosis in epithelial ovarian cancer.Discovery of 4,6-substituted-(diaphenylamino)quinazolines as potent c-Src inhibitors.
P2860
Expression of c-Src and phospho-Src in epithelial ovarian carcinoma.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Expression of c-Src and phospho-Src in epithelial ovarian carcinoma.
@en
Expression of c-Src and phospho-Src in epithelial ovarian carcinoma.
@nl
type
label
Expression of c-Src and phospho-Src in epithelial ovarian carcinoma.
@en
Expression of c-Src and phospho-Src in epithelial ovarian carcinoma.
@nl
prefLabel
Expression of c-Src and phospho-Src in epithelial ovarian carcinoma.
@en
Expression of c-Src and phospho-Src in epithelial ovarian carcinoma.
@nl
P2093
P2860
P1476
Expression of c-Src and phospho-Src in epithelial ovarian carcinoma.
@en
P2093
Jun-Dong Li
Man-Man Xu
Xiao-Feng Zhu
Yong-Wen Huang
P2860
P2888
P356
10.1007/S11010-012-1550-1
P577
2013-01-01T00:00:00Z